Efficacy and Safety Study of SAL-0951 in the Treatment of Renal Anemia in Patients Receiving Peritoneal Dialysis

NCT06720233 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: SAL-0951 tablets

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.